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Copyright © 200? JCBN Summary Our objective was to examine the effect of orange juice and hesperetin on serum
total antioxidant capacity (TAC), lipid peroxidation (MDA), uric acid and hepatic xanthine
oxidase (XO) and xanthine dehydrogenase (XDH) activity in hyperuricemic rats. Experi-
mentally hyperuricemia in rats was induced by intraperitoneal injection of potassium oxonate
(250 mg/kg). Orange juice (5 ml/kg) and hesperetin (5 mg/kg) was given by oral gavage to rats
for 2 weeks and biochemical data was measured. Data showed that orange juice supple-
mentation increased serum TAC and decreased MDA concentration (p≤0.05). Orange juice
also inhibited hepatic XO and XDH activity and decreased serum uric acid levels. Hesperetin,
which is the main flavanone constituent in orange juice, also exhibited antioxidative and
antihyperuricemic properties, but its effect was weaker than that of orange juice. Although the
hypouricemic effect of allopurinol (5 mg/kg), as a positive control, was much higher than that
of orange juice and hesperetin, it could not significantly change biomarkers of oxidative stress.
These features of orange juice and hesperetin make them an attractive candidate for the
prophylactic treatment of hyperuricaemia, particularly if these compounds are to be taken on
a long-term basis.
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Introduction
Hyperuricemia, characterized by abnormal high levels of
uric acid, is a common metabolic disorder with a worldwide
distribution [1]. It has been considered as an important risk
factor for gout and may be associated with oxidative stress
conditions [2]. That is way the control of uric acid produc-
tion has been widely considered as a key factor in the
prevention and treatment of these diseases [3]. Xanthine
oxidoreductase (XOR), a molybdenum-containing enzyme,
is the key enzyme in the catabolism of purines; that catalyses
the oxidative hydroxylation of hypoxanthine to xanthine and
xanthine to the terminal catabolite uric acid [4]. It is worth
noting that XOR occurs in two different forms. Xanthine
dehydrogenase (XDH) is the prevalent operative form under
physiological conditions and has greater affinity for oxidized
nicotinamide adenine dinucleotide (NAD+) compared to
oxygen, as the electron acceptor. Under pathological condi-
tions, however, in parallel to the degradation of ATP intoF. Haidari et al.
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adenine and xanthine, an extensive conversion of XDH to
xanthine oxidase (XO) takes place. The latter uses molecular
oxygen in place of NAD+ as electron acceptor and leads to
the formation of superoxide anion and hydrogen peroxide in
parallel with uric acid production. Therefore, XOR can act
as a source of reactive oxygen species (ROS) [5]. ROS
may be involved in the pathogenesis of various degenerative
diseases because they induce damage to biological macro-
molecules such as proteins, fats and DNA [6]. That is way
the inhibition of XOR activity may be decrease the level
of uric acid and ROS production, and results in anti-
hyperuricemic and antioxidative effects.
Allopurinol is the sole XOR inhibitor under the clinical
application and has served as a dominant uric acid-lowering
agent in the past three decades [7]. However, some severe
adverse effects such as hepatitis, nephropathy and allergic
reactions limit the clinical use of allopurinol and it would
be highly desired to search for new XOR inhibitors, in
particular from natural sources, as alternatives for allopurinol
[2, 4, 8].
Flavonoids are non-nutrient polyphenolic compounds that
occur in edible plants and consist of six major classes based
on specific structural differences: flavonols, flavones,
flavanones, catechins, anthocyanidins, and isoflavones.
Flavonoids possess a wide range of biochemical and
pharmacological effects and have been recommended as
chemopreventive agents or nutritional supplements [6, 9].
The predominant mechanism of their biological actions is
thought to result from antioxidant activity, enzyme inhibi-
tion, and the capacity to scavenge free radicals [10, 11].
XOR is one of the most important enzymes that are inhibited
by some flavonoids [12].
Hesperetin (3',5,7-trihydroxy-4'-methoxyflavanone), which
occurs as hesperidin (its glycoside form) in nature, belongs
to flavanone subclass of flavonoids and is mainly found in
citrus fruits such as orange [13, 14]. There is significant
interest in the direct antioxidant activities of citrus flava-
nones hesperidin and hesperetin, due to associations
between consumption of flavanone-rich fruits, such as
orange and decreased incidence of oxidative stress related
disease [15–17]. However, indirect antioxidant action, such
as the inhibition of ROS-producing enzymes, may be
equally relevant to health benefits through a general reduc-
tion in oxidative stress in vivo. Although hesperetin pro-
duced from hesperidin is actually bioactive molecule in the
body, only a few in vitro and in vivo studies have assessed
hesperetin, rather than hesperidin.
In this study, the effects of orange juice and hesperetin on
the in vivo activity of XO and XDH and serum uric acid
levels were assessed in oxonate-induced hyperuricemic rats,
many for the first time. The possible role of those in
reducing biomarkers of oxidative stress was also investi-
gated.
Materials and Methods
Chemicals
Hesperetin, potassium oxonate, xanthine, NAD+, uric
acid, allopurinol, tetraethoxypropane (TEP), trichloroacetic
acid (TCA), 2-thiobarbituric acid (TBA), bicinchoninic acid
kit and 6-mercaptopurine were purchased from Sigma-
Aldrich Chemical Co. (Steinheim, Germany). All other
reagents used were from of analytical grades. Orange (Citrus
sinensis L.) was purchased from a wholesale market.
Test compound preparation
Orange is commonly peeled and squeezed for its juice.
Hesperetin was first dissolved in propylene glycol and then
added 0.9% saline (1:20 V:V). Allopurinol used as a positive
control, was prepared in 0.9% saline.
Animals
A total of 30 male Wistar rats (body weights: 180–200 g)
were obtained from the animal house of Tabriz University of
Medical Sciences, Iran. They were fed with a commercial
laboratory diet and allowed food and water ad libitum for
an acclimatization period of 1 week prior to the experiment.
All animals were maintained on a 12 h/12 h light/dark cycle
and the temperature and humidity were kept at 18 ± 1°C
and 50%, respectively. They were handled according to the
recommendation of the local and national ethic committees.
Animal model of hyperuricemia in rats
Experimentally-induced hyperuricemia in rats (due to
inhibition of uricase with potassium oxonate) was used to
study anti-hyperuricemic and antioxidant effects of test
compounds [18]. Briefly, 250 mg/kg potassium oxonate
(PO) dissolved in 0.9% saline solution was administrated
intraperitonially to each animal 1 h before oral administra-
tion of test compounds.
Experimental design
This study was conducted from April 2008 to Oct 2008.
Rats were randomly divided into five equal groups (6 rats
per group). In group 1, the normal group, each animal
received only water as vehicle. In group 2, the hyperure-
cemic control group, uricase inhibitor PO (250 mg/kg) was
administrated intraperitoneally. In groups 3, 4 and 5, each
animal received the same dose of PO 1 h before admin-
istration of 5 ml/kg orange juice, 5 mg/kg hesperetin and
5 mg/kg allopurinol, respectively. The freshly prepared
samples were administrated to corresponding groups by
oral gavage once a day for 2 weeks.
Sample preparation
At the end of the experiment, rats were anesthetized
between 09.00 and 10.00 am. Blood was taken from theOrange Juice and Hesperetin Supplementation
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abdominal aorta 1 h after the test compound administration.
Serum was obtained by centrifuging blood sample at 6000 g
for 10 min. For the high performance liquid chromatography
(HPLC) analysis, the serum was filtered using SPARTAN
13/0.45 RC, Watman (USA). The sera were stored at −20°C
until use.
After blood sampling, livers were removed, weighed
and then rapidly washed in 0.9% cold saline and placed in
ice-cold isotonic potassium chloride solution (1.15% KCl
w/v) containing 0.1 mM EDTA. The livers were then
chopped into 4–5 volumes of 50 mM phosphate buffer
(pH 7.4) and homogenized by a homogenizer fitted with a
Teflon pestle. The homogenate was then centrifuged at
3000 g for 10 min, the lipid layer was carefully removed,
and the resulting supernatant fraction was further centrifuged
at 15,000 g for 60 min at 4°C. The supernatant stored at
−80°C until use.
Uric acid determination
The serum uric acid levels were analyzed by HPLC
method using a system supplied by Waters Associates
(Northwich, Cheshire) which consisted of a Waters 515
pump, Waters 717 plus Autosampler, Waters 2487, Dual λ
Absorbance Detector. The mobile phase was a mixture of
100 mM KH2PO4 (pH 3.5): Methanol (97:3, v/v). Separa-
tions were performed on a C-18 column (Perfectsil Target
ODS-3 (5 μm), 250 × 4.6 mm) with a C-18 guard column
(Perfectsil Target ODS-3 (5 μm), 10 × 4 mm). The effluent
was monitored by UV detection at 290 nm at a flow rate of
1.0 ml/min. Standard solutions of uric acid in the range of
10 to 1000 μM/L were prepared in mobile phase. Serum
uric acid concentrations were expressed as μM/L. 6-
Mercaptopurine (1 mM) was used as the internal standard.
The percentage decrease in serum uric acid levels was
calculated as [(CC–CT)/(CC–CN)] *100, where CC, CN,
and CT are the uric acid concentrations (μM/L) of control
(PO treated), normal (without PO treatment), and test
(PO + test compounds treated) groups.
XO and XDH activities determination
The XO and XDH activities were measured spectrophoto-
metrically by monitoring the production of uric acid from
xanthine according to Prajda and Weber’s method [19]. In
the case of XDH, the assay mixture consisted of 50 μM
xanthine, 50 μM phosphate buffer (pH 7.4), 200 μM NAD+,
and 100 μl of the enzyme solution. After preincubation at
37°C for 15 min, the reaction was initiated by the addition
of the substrate solution. After 30 min, the reaction was
terminated by adding 0.5 ml HCl (0.6 M), and the absor-
bance was measured at 290 nm using a Shimadzu 2550
UV/VIS spectrophotometer which was controlled by the
Shimadzu UV Probe personal software package including
kinetics software (Shimadzu, Kyoto, Japan). The instrument
was connected to a Shimadzu cell temperature control unit.
XO activity was measured using a similar method described
for XDH with the difference being that molecular oxygen
was used in place of NAD+ as electron acceptor. One unit
(U) of activity was defined as 1 nM of uric acid formed per
minute at 37°C, pH 7.4.
Protein determination
Protein concentration was determined spectrophoto-
metrically by bicinchoninic acid kit using bovine serum
albumin as the standard.
Total antioxidant capacity (TAC) assay
Total serum antioxidant capacity assay was performed
using TPTZ (tripyridyltriazine) reagent. This method mea-
sures the ability of the antioxidants contained in the sample
to reduce ferrictripiridyltriazine (Fe3+-TPTZ) to a ferrous
form (Fe2+) which absorbs light at 593 nm. TAC of serum
was calculated by plotting a standard curve of absorbance
against μM/L concentration of Fe2+ standard solution [20].
Lipid peroxide determination
Lipid peroxide in the serum was measured according to
the method of Yoshioka et al. [21].
Statistical analysis
All the samples and standards were run in duplicate and
the results were expressed as means ± standard deviation
(SD). The statistical comparison of each experimental group
with control group was performed by Independent-sample
t test using SPSS computer program. The probabilities of
5% or less (p≤0.05) were considered significant.
Results
As shown in Table 1, potassium oxonate administration
can lead to a decrease in serum total antioxidant capacity in
hyperuricemic control rats compared to normal rats. As it is
also obvious in Table 1, a significant increase (p≤0.05) in
serum total antioxidant capacity after orange juice admin-
istration compared to hyperuricemic control group (280 ±
30.16 vs 213 ± 65.92 μM/L) was observed.
As also shown in Table 1, in hyperuricemic control rats,
the level of serum malondialdehyde (MDA), as a biomarker
of lipid peroxidation, was statistically higher than that of
normal rats (p≤0.05). Orange juice administration was also
significantly able to decrease MDA concentration compared
to hyperuricemic control rats (p≤0.05). Hesperetin and
Allopurinol treatment could not significantly increase serum
total antioxidant capacity or decrease MDA concentration in
this study (p≥0.05).
The effects of the orally administered orange juice and
hesperetin on hepatic XO and XDH activity are shownF. Haidari et al.
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in Table 2. In oxonate-pretreated rats, orange juice and
hesperetin resulted in significant inhibition on both hepatic
XO and XDH activity. The inhibitory effect of orange juice
on XO and XDH activity was 24.49% (p≤0.05) and 30.89%
(p≤0.001), respectively. Hesperetin treatment caused
23.69% (p≤0.05) and 20.68% (p≤0.05) inhibition on XO
and XDH activity, respectively. Allopurinol, as a positive
control, significantly decreased the mean activity of XO and
XDH, respectively by 57.83% (p≤0.001) and 66.75%
(p≤0.001).
As shown in Fig. 1, intraperitoneal injection of potassium
oxonate (250 mg/kg) to control group markedly increased
the serum uric acid levels, and reached to 214.36 ± 26.42
(μM/L) at the end of the experiment. The uric acid level in
normal rats was only 99.87 ± 17.44 (μM/L).
As also shown in Fig. 1, oral administration of orange
juice and hesperetin significantly decreased the serum uric
acid levels in hyperuricemic rats. The extents of reduction
for orange juice and hesperetin were 38.76% and 24.93%,
respectively. The reference drug allopurinol substantially
reduced the uric acid level by 124%. It is worth to note that
in present study, we found a positive correlation between
serum uric acid levels and MDA concentration (Fig. 2).
Discussion
Hyperuricemia is a metabolic disorder which may play an
important role in the development of gout and oxidative
stress related disease such as cancer and cardiovascular
diseases [2,  22]. At the present, allopurinol, a purine
analogue, which causes inhibition on XOR, is the only drug
with clinical application to lower uric acid production [7].
Due to some serious side effects of this drug, many attempts
are made to find a safer alternative for allopurinol parti-
cularly from natural sources [2, 23–25].
Positive healthy effects of flavonoids and diets rich in
these compounds have been reported in several diseases.
Flavonoids have been described as health-promoting,
disease-preventing dietary supplements because they are
extremely safe and associates with low toxicity, making
them to be excellent candidates for agents [26]. In the
present  in vivo investigation, the effects of orange juice
(5 ml/kg) and hesperetin (5 mg/kg) on biomarkers of oxida-
tive stress, serum uric acid levels and hepatic XO and XDH
activity in oxonate-induced hyperuricemic rats were assessed,
many for the first time.
Following treatment of the hyperuricemic rats with
orange juice a significant increase (p≤0.05) in serum total
antioxidant capacity compared to hyperuricemic control was
found. Orange juice administration was also significantly
able to decrease serum MDA levels, a marker of lipid
peroxidation, compared to hyperuricemic control rats
(p≤0.05). Flavonoids presenting in orange juice possess
antioxidant properties and suppress destructive oxygen free
radicals. An overabundance of free radicals can damage all
components of the cell, including proteins, fats and DNA,
Table 1. Effect of orange juice, hesperetin and allopurinol on
serum TAC and MDA
All values are expressed as mean ± SD (n = 6). Independent-
sample t test was used for statistical significance assessment. * indi-
cates p≤0.05 vs hyperuricemic control group, # indicates p≤0.05,
## indicates p≤0.01 and ### indicates p≤0.001 vs normal control
group.
Treatment TAC (μmol/L) MDA (μmol/L)
Normal animal
Vehicle 275 ± 78.67* 3.41 ± 0.57
Hyperuricemic animal
PO + vehicle 213 ± 65.92# 5.45 ± 0.89###
PO + orange juice (5 ml/kg) 280 ± 30.16* 4.04 ± 0.86*
PO + hesperetin (5 mg/kg) 271 ± 52.31 4.95 ± 0.71##
PO + allopurinol (5 mg/kg) 244 ± 57.27 5.00 ± 0.92##
Table 2. Effect of orange juice, hesperetin and allopurinol on hepatic XO and XDH activity
All values are expressed as mean ± SD (n = 6). Independent-sample t test was used for statistical significance assessment.
* indicates p≤0.05, and *** indicates p≤0.001 vs hyperuricemic control group, # indicates p≤0.05, ## indicates p≤0.01 and
### indicates p≤0.001 vs normal control group.
Treatment Activity (U/mg protein) Inhibition %
XO XDH XO XDH
Normal animal
Vehicle 2.50 ± 0.63 3.80 ± 0.38 — —
Hyperuricemic animal
PO + vehicle 2.49 ± 0.52 3.82 ± 0.62 — —
PO + orange juice (5 ml/kg) 1.88 ± 0.37*,# 2.64 ± 0.20***,### 24.49 30.89
PO + hesperetin (5 mg/kg) 1.90 ± 0.37*,# 3.03 ± 0.29*,## 23.69 20.68
PO + allopurinol (5 mg/kg) 1.05 ± 0.18***,### 1.27 ± 0.33***,### 57.83 66.75Orange Juice and Hesperetin Supplementation
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contributing to the development of several pathological
conditions [9, 27].
In oxonate-pretreated control rats, a significant increase in
serum MDA levels and decrease in serum total antioxidant
capacity was found. Potassium oxonate, a selectively
competitive uricase inhibitor, blocks the effect of hepatic
uricase and produces hyperuricemia in rodents [18].
Increased uric acid level has been associated with increased
production of oxygen free radicals, due to the conversion
of XDH to XO that plays a pivotal role in progression of
oxidative stress condition [5]. In present study, uric acid
was positively correlated with MDA. XO is a source of
ROS and may explain the link between hyperuricemia and
oxidative stress-induced diseases [2, 4, 5]. Moreover, serum
uric acid elevation may promote oxygenation of LDL-C and
facilitate lipid peroxidation [28]. This capacity of XO makes
the enzyme the focus of interest in many recent biochemical
and clinical studies [5]. From the above discussion we can
assume that serum uric acid through lipid peroxidation,
might be working towards the etiopathogenesis of ROS-
mediated diseases and its serum level may be a deciding
factor for progression of the disease.
Our study also showed that orange juice has a higher
potential than hesperetin to improve total antioxidant
capacity and to reverse MDA. In orange, hesperidin
(hesperetin 7-O-beta-rutinoside) is predominant and it is
well known that the bioavailability of hesperidin in orange is
higher than that of its aglycon [29]. Therefore, the higher
efficiency of orange juice compared to hesperetin to
improve biomarkers of oxidative stress could be attributed
to its higher intestinal absorption. Furthermore, it is possible
that the other flavonoids except hesperetin -studied in this
investigation- to be responsible for the antioxidative effects
of orange juice. In this study, allopurinol could not signifi-
cantly increase total antioxidant capacity or decrease MDA
concentration in hyperuricemic rats. However, the inhibition
of XO by allopurinol was previously reported to decrease
the level of ROS production and reduce the hepatic injury
associated with liver transplantation [25].
We also showed that the orally administered orange
juice (5 ml/kg) and hesperetin (5 mg/g) could significantly
decrease the uric acid levels compared to hyperuricemic
control rats, but the mean levels of uric acid in these treated
animals were yet higher than that of normal values. In this
study, we did not investigate the dose response effect of
them. It is speculated that the higher dosage of orange juice
and hesperetin may be more effective in this regards.
It is important to note that, orange juice was more potent
than hesperetin to attenuate and or to reverse hyperuricemia.
Fig. 1. Effect of orange juice, hesperetin and allopurinol on serum uric acid. All values are expressed as mean ± SD (n =6 ) .
Independent-sample  t test was used for statistical significance assessment. * indicates p≤0.05,  ** indicates p≤0.01 and
*** indicates p≤0.001 vs hyperuricemic control group. The number above bars means the percent of uric acid reduction vs
hyperuricemic control group.
Fig. 2. Linear regression between serum uric acid levels and
MDA concentrationF. Haidari et al.
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As it is mentioned before, the less bioavailability of
hesperetin aglycon than that of hesperetin glycosides
representing in orange juice may be responsible for this
finding. However, the effect of allopurinol, as a reference
drug on reducing uric acid level was even more potent and
reached serum uric acid levels to a lower level than that of
normal levels (72.38 ± 0.32 vs 99.87 ± 0.29 μM/L). On the
other hand, this property of orange juice and hesperetin
could be considered as an advantage for them. Although the
elevated levels of uric acid in the circulation could give rise
to gout and possibly other pathological conditions [22], the
antioxidant action of uric acid, particularly its ability to
inhibit DNA damage, is also well documented [30]. Thus,
excessive lowering of the uric acid level in the circulation
beyond that of the normal range might even be counter
productive [8]. These data also indicated that orange juice
and hesperetin might bring fewer side effects than allo-
purinol in treatment of hyperuricemia and oxidative stress
related diseases.
In oxonate-pretreated rats, orange juice and hesperetin
resulted in significant inhibition on both hepatic XO and
XDH activity. Several in vitro studies confirmed the
competitive inhibition of flavonoids such as hesperetin
and naringenin on XDH and XO activity. Structure–activity
relationships of flavonoids have been proposed for the
enzyme inhibitory effect of them. Due to the presence of
several hydroxyl moieties on the carbon atoms of the basic
skeleton, flavonoids may interact with active site of XDH
and XO and inhibit them [1, 11]. Therefore the hypouricemic
property of orange juice and hesperetin observed in this
study could be explained by the inhibitory effect of them on
XDH and XO activity; however, there is not apparently a
parallel relationship between the extent of the hypouricemic
action and the reduction in the enzyme activity. Therefore,
the observed hypouricemic effect can not be entirely
attributed to this mechanism. Similar results have been
reported by others [8, 23, 24]. According to these studies,
the involvement of other possible mechanisms such as
enhanced uric acid clearance or actions on other purine
metabolizing enzymes can not be ruled out [8, 23]. This could
be further supported by the existence of some hypouricemic
compounds including natural products that are devoid of
XDH and XO inhibitory activity [8, 31].
In conclusion, orange juice and hesperetin prevented
oxidative stress by enhancing total antioxidant capacity and
decreasing lipid peroxidation. However, the hypouricemic
and XOR inhibitory action of orange juice (5 ml/kg) and
hesperetin (5 mg/kg) was significant in this study; but this
effect was partially weak and they could not reach the uric
acid levels to the normal values in hyperuricemic rats. The
higher dosage of orange juice and hesperetin should be
investigated later. As orange is the most frequently con-
sumed fruit in almost throughout the world and can be used
safely long-term, this natural food could be served as a
possible alternative for allopurinol, or at least in combina-
tion therapy to minimize the side-effects of allopurinol.
Further investigations to explore the effect of other compo-
nents of orange (Citrus sinensis L.) and to define their
clinical efficacy would be highly desirable. Furthermore, the
search for safe anti-hyperuricemic and antioxidative foods
and diets must continue.
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